| Revenue growth | 28.2% YoY growth in FY26 to ₹39,308 Mn. |
|---|---|
| Margins | EBITDA margins compressed from 26.6% to 21.1%. |
| Demand visibility | Strong, evidenced by 25.4% growth in OP volumes. |
| Management confidence | High on regional leadership and clinical excellence strategy. |
Growth
FY26 Total Revenue grew 28.2% YoY; EBITDA grew 1.6% but margins compressed to 21.1% from 26.6% in FY25.
Outlook
Planned expansion to 8600+ beds including greenfield projects in Chennai (300 beds) and Kondapur II (800 beds).
Risks
PAT declined 41.7% YoY in FY26 due to expansion-related costs and initial losses in new clusters like Karnataka.
Earnings Call filed with NSE, NSE: KIMS. Summary written with AI assistance from the document.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹780.15
- Market cap
- ₹32,767 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 160.4×Sector 57.8×
- Promoter holding
- 32.50%-1.61% QoQ
- FII holding
- 14.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Share Pledge
Promoters pledged 2,80,08,979 equity shares (6.66%) to Catalyst Trusteeship as debenture trustee. The pledge secures existing debenture obligations with no new capital involved.
Krishna Institute of Medical Sciences Capacity Expansion
Krishna Institute of Medical Sciences Ltd entered an Operations and Management Agreement with Sarvottam Health Care Pvt Ltd for 5+5 years to manage their operations.
- Execution
- 5 years with an extension for a further period of 5 years
Krishna Institute of Medical Sciences Earnings Call Transcript: Key Takeaways
KIMS delivered strong EBITDA margins despite lower ARPOB compared to peers, driven by lean operational efficiency and high patient volumes.
Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways
KIMS reported strong Q1 FY27 results with consolidated operating revenue growth of 35.3% YoY and 9.8% QoQ, driven by expansion and higher occupancy in core clusters.
Krishna Institute of Medical Sciences Q1 FY27 Results: Net Profit ₹37.4 Cr, Down 56.0% YoY
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,180 Cr (+35.3% YoY) and net profit of ₹37.4 Cr (-56.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹37.4 Cr · -56.0% YoY
Krishna Institute of Medical Sciences Earnings Call: Key Takeaways
KIMS Hospitals Q4 FY26 earnings call highlighting robust 35.3% revenue growth to INR 1,084cr, despite EBITDA margin contraction to 19.9% due to heavy expansion and new unit drags.